For a company trying to sell itself, Biogen s shares sure have been sagging. Yesterday, they stood at $70.83 in 4 pm trading, a 14% drop from their ...
Biogen Idec s been the biotech flavor of the month ever since it said it was for sale. Speculation has put Pfizer, hungry for new products and a big...
As the reign of Pfizer CEO Hank McKinnell was entering its twilight almost two years ago, he fired off a short, internal email asking whether it was t...
Filed under: Drug, All CancersThe New York Times recently profiled pay-for-performance and risk-sharing pricing arrangements for high-cost drugs, incl...
Multiple sclerosis (MS) is one of the most common diseases of the central nervous system. Today over 2,500,000 people around the world have MS.MS is t...
Here's a follow-up to our popular post about transgenic pigs makingdrugs in their milk. Oxford Biomedica and Viragen, Inc. yesterday announced that th...
Here's a follow-up to our popular post about transgenic pigs makingdrugs in their milk. Oxford Biomedica and Viragen, Inc. yesterday announced that th...